Prior Auth Required

81418 - genes, including CYP2C19, CYP2D6, and CYP2D6 duplication/deletion analysis

This procedure appears on the selected insurer prior authorization source.

Check another codeExplore policy data
Prior authorizationPrior Auth Required
Procedure / Servicegenes, including CYP2C19, CYP2D6, and CYP2D6 duplication/deletion analysis
Procedure / Service Description

Drug metabolism (eg, pharmacogenomics) genomic sequence analysis panel, must include testing of at least 6 - 81415 Exome (eg, unexplained constitutional or heritable disorder or syndrome); sequence analysis Drug metabolism (eg, pharmacogenomics) genomic sequence analysis panel, must include testing of at least 6 81418 genes, including CYP2C19, CYP2D6, and CYP2D6 duplication/deletion analysis Hereditary peripheral neuropathies (eg, Charcot-Marie-Tooth, spastic paraplegia), genomic sequence analysis panel, must include sequencing of at least 5 peripheral neuropathy-related genes (eg, BSCL2, GJB1, MFN2,

Likely documents
  • Confirm benefit details
  • Submit clinical notes if requested by the plan
Next actions
  • Confirm the current plan policy before submission.
  • Use the insurer authorization workflow for this listed code.